Es gab 50 kürzliche Insider-Transaktionen für Tenax Therapeutics, Inc. (TENX), darunter 44 Käufe und 1 Verkauf. Die gesamten Insider-Käufe beliefen sich auf $39.39M und die gesamten Insider-Verkäufe auf RSU Award.
Bedeutende Insider mit kürzlicher Aktivität umfassen Mcgauley Thomas, Proehl Gerald T, Almenoff June Sherie. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — TENX
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-01-30 |
Mcgauley Thomas |
Interim CFO |
Optionsausübung |
50,000 |
$12.51 |
$625.5K |
50,000 |
| 2026-01-09 |
Proehl Gerald T |
Director |
RSU-Zuteilung |
3,000 |
$13.30 |
$39.9K |
30,000 |
| 2026-01-09 |
Almenoff June Sherie |
Director |
RSU-Zuteilung |
30,000 |
$13.30 |
$399K |
30,000 |
| 2026-01-09 |
Davidson Michael H. |
Director |
RSU-Zuteilung |
30,000 |
$13.30 |
$399K |
30,000 |
| 2026-01-09 |
Doogan Declan |
Director |
RSU-Zuteilung |
30,000 |
$13.30 |
$399K |
30,000 |
| 2026-01-09 |
Hunter Robyn |
Director |
RSU-Zuteilung |
30,000 |
$13.30 |
$399K |
30,000 |
| 2026-01-09 |
Rich Stuart |
Chief Medical Officer |
RSU-Zuteilung |
250,000 |
$13.30 |
$3.33M |
250,000 |
| 2026-01-09 |
Giordano Christopher Thomas |
CEO |
RSU-Zuteilung |
450,000 |
$13.30 |
$5.99M |
450,000 |
| 2025-12-09 |
Rich Stuart |
Chief Medical Officer |
Informierter Kauf |
2,500 |
$10.22 |
$25.54K |
5,266 |
| 2025-12-08 |
Rich Stuart |
Chief Medical Officer |
Informierter Kauf |
2,500 |
$10.10 |
$25.25K |
5,000 |
| 2025-12-04 |
Rich Stuart |
Chief Medical Officer |
Informierter Kauf |
2,500 |
$9.20 |
$23K |
2,500 |
| 2025-12-03 |
Rich Stuart |
Chief Medical Officer |
Informierter Kauf |
1,500 |
$9.08 |
$13.62K |
2,766 |
| 2025-12-02 |
Rich Stuart |
Chief Medical Officer |
Informierter Kauf |
1,000 |
$9.01 |
$9.01K |
1,266 |
| 2025-11-20 |
Giordano Christopher Thomas |
CEO |
Informierter Kauf |
538 |
$7.59 |
$4.08K |
2,605 |
| 2025-11-19 |
Giordano Christopher Thomas |
CEO |
Informierter Kauf |
455 |
$7.51 |
$3.42K |
2,067 |
| 2025-11-18 |
Almenoff June Sherie |
Director |
Informierter Kauf |
1,900 |
$7.52 |
$14.28K |
1,993 |
| 2025-11-18 |
Giordano Christopher Thomas |
CEO |
Informierter Kauf |
1,612 |
$7.75 |
$12.5K |
1,612 |
| 2025-11-17 |
Almenoff June Sherie |
Director |
Informierter Kauf |
93 |
$7.15 |
$664.95 |
93 |
| 2025-11-17 |
Mcgauley Thomas |
Interim CFO |
Informierter Kauf |
1,000 |
$7.35 |
$7.35K |
1,000 |
| 2025-07-01 |
Proehl Gerald T |
Director |
RSU-Zuteilung |
80,000 |
$5.75 |
$460K |
80,000 |
| 2025-07-01 |
Almenoff June Sherie |
Director |
RSU-Zuteilung |
80,000 |
$5.75 |
$460K |
80,000 |
| 2025-07-01 |
Davidson Michael H. |
Director |
RSU-Zuteilung |
80,000 |
$5.75 |
$460K |
80,000 |
| 2025-07-01 |
Doogan Declan |
Director |
RSU-Zuteilung |
80,000 |
$5.75 |
$460K |
80,000 |
| 2025-07-01 |
Hunter Robyn |
Director |
RSU-Zuteilung |
80,000 |
$5.75 |
$460K |
80,000 |
| 2025-05-16 |
Rich Stuart |
Chief Medical Officer |
RSU-Zuteilung |
625,000 |
$5.89 |
$3.68M |
625,000 |
| 2025-05-16 |
Giordano Christopher Thomas |
CEO |
RSU-Zuteilung |
1,400,000 |
$5.89 |
$8.25M |
1,400,000 |
| 2025-03-05 |
Dellora Investments Lp |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2025-01-08 |
Dellora Investments Lp |
10 Percent Owner |
Unbekannt |
- |
- |
- |
351,071 |
| 2024-12-10 |
Proehl Gerald T |
Director |
RSU-Zuteilung |
100,000 |
$5.94 |
$594K |
100,000 |
| 2024-12-10 |
Almenoff June Sherie |
Director |
RSU-Zuteilung |
100,000 |
$5.94 |
$594K |
100,000 |
| 2024-12-10 |
Davidson Michael H. |
Director |
RSU-Zuteilung |
100,000 |
$5.94 |
$594K |
100,000 |
| 2024-12-10 |
Doogan Declan |
Director |
RSU-Zuteilung |
100,000 |
$5.94 |
$594K |
100,000 |
| 2024-12-10 |
Hunter Robyn |
Director |
RSU-Zuteilung |
100,000 |
$5.94 |
$594K |
100,000 |
| 2024-12-10 |
Rich Stuart |
Chief Medical Officer |
RSU-Zuteilung |
500,000 |
$5.94 |
$2.97M |
500,000 |
| 2024-12-10 |
Giordano Christopher Thomas |
CEO |
RSU-Zuteilung |
1,250,000 |
$5.94 |
$7.43M |
1,250,000 |
| 2024-12-02 |
Mcgauley Thomas |
Interim CFO |
Unbekannt |
- |
- |
- |
- |
| 2024-08-08 |
Proehl Gerald T |
Director |
Informierter Kauf |
1,666 |
$3.00 |
$5K |
1,667 |
| 2024-08-08 |
Davidson Michael H. |
Director |
Informierter Kauf |
2,500 |
$3.00 |
$7.5K |
2,881 |
| 2024-05-17 |
Rich Stuart |
Chief Medical Officer |
RSU-Zuteilung |
119 |
$3.55 |
$422.33 |
119 |
| 2024-05-17 |
Giordano Christopher Thomas |
CEO |
RSU-Zuteilung |
437 |
$3.55 |
$1.55K |
437 |
| 2024-01-11 |
Hoffman Lawrence R |
Interim CFO |
Veräußerung |
- |
- |
- |
- |
| 2022-09-21 |
Rich Stuart |
10 Percent Owner, Officer: Chief Medical Officer |
Schenkung (gegeben) |
1,909,585 |
- |
- |
424,347 |
| 2022-08-11 |
Doogan Declan |
Director |
Schenkung (gegeben) |
567,871 |
- |
- |
- |
| 2022-06-09 |
Proehl Gerald T |
Director |
RSU-Zuteilung |
5,000 |
$0.62 |
$3.1K |
5,000 |
| 2022-06-09 |
Almenoff June Sherie |
Director |
RSU-Zuteilung |
5,000 |
- |
- |
5,000 |
| 2022-06-09 |
Davidson Michael H. |
Director |
RSU-Zuteilung |
5,000 |
$0.62 |
$3.1K |
5,000 |
| 2022-06-09 |
Doogan Declan |
Director |
RSU-Zuteilung |
5,000 |
- |
- |
5,000 |
| 2022-06-09 |
Hunter Robyn |
Director |
RSU-Zuteilung |
6,250 |
$0.62 |
$3.88K |
6,250 |
| 2022-06-09 |
Rich Stuart |
10 Percent Owner, Officer: Chief Medical Officer |
RSU-Zuteilung |
100,000 |
$0.62 |
$62K |
100,000 |
| 2022-06-09 |
Giordano Christopher Thomas |
CEO |
RSU-Zuteilung |
200,000 |
- |
- |
200,000 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
